IL102565A0 - Expression of enzymatically active recombinant human acetylcholinesterase and uses thereof - Google Patents

Expression of enzymatically active recombinant human acetylcholinesterase and uses thereof

Info

Publication number
IL102565A0
IL102565A0 IL102565A IL10256592A IL102565A0 IL 102565 A0 IL102565 A0 IL 102565A0 IL 102565 A IL102565 A IL 102565A IL 10256592 A IL10256592 A IL 10256592A IL 102565 A0 IL102565 A0 IL 102565A0
Authority
IL
Israel
Prior art keywords
expression
recombinant human
enzymatically active
active recombinant
human acetylcholinesterase
Prior art date
Application number
IL102565A
Original Assignee
Bio Technology General Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/732,962 external-priority patent/US5248604A/en
Application filed by Bio Technology General Corp filed Critical Bio Technology General Corp
Publication of IL102565A0 publication Critical patent/IL102565A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • C12Q1/46—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase involving cholinesterase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Enzymes And Modification Thereof (AREA)
IL102565A 1991-07-22 1992-07-20 Expression of enzymatically active recombinant human acetylcholinesterase and uses thereof IL102565A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73341891A 1991-07-22 1991-07-22
US07/732,962 US5248604A (en) 1991-07-22 1991-07-22 Enzymatically active recombinant human acetylcholinesterase and hosts and vectors for expression thereof

Publications (1)

Publication Number Publication Date
IL102565A0 true IL102565A0 (en) 1993-01-14

Family

ID=27112494

Family Applications (1)

Application Number Title Priority Date Filing Date
IL102565A IL102565A0 (en) 1991-07-22 1992-07-20 Expression of enzymatically active recombinant human acetylcholinesterase and uses thereof

Country Status (5)

Country Link
EP (1) EP0591472A1 (en)
AU (1) AU2487192A (en)
IL (1) IL102565A0 (en)
NZ (1) NZ243654A (en)
WO (1) WO1993001830A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1072722C (en) * 1997-12-30 2001-10-10 中国科学院上海细胞生物学研究所 Method of screening anti-tumour medicine and determining clinical chemotherapy effect
WO2006076024A2 (en) * 2004-05-14 2006-07-20 University Of Miami A method for targeting synapse with acetylcholinesterase
TWI688657B (en) * 2018-06-11 2020-03-21 吾幫土智慧生活有限公司 Nucleic acid, inducible recombinant plasmid, transformant, non-glycosylated acetylcholinesterase and preparation method thereof
CN113637653B (en) * 2021-08-05 2023-05-23 云南师范大学 Esterase mutant Est8-XL with improved activity and application thereof
CN113777088B (en) * 2021-09-30 2023-08-29 马鞍山普梅森医学检验实验室有限公司 Fluorescent detection method of acetylcholinesterase based on carbon dots

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8401798L (en) * 1984-04-02 1985-10-03 Erik Dahlgren INDICATING TABLE FOR NERVAS AND OTHER CHOLINE EASY INHIBITORS
IL75553A (en) * 1985-06-18 1993-07-08 Yeda Res & Dev Dna sequence coding for a cholinesterase-like peptide, peptides produced by cells containing said dna and antibodies thereto

Also Published As

Publication number Publication date
AU2487192A (en) 1993-02-23
EP0591472A1 (en) 1994-04-13
NZ243654A (en) 1994-09-27
WO1993001830A1 (en) 1993-02-04

Similar Documents

Publication Publication Date Title
GB2200048B (en) Hydrosols of pharmacologically active agents and pharmaceutical compositions comprising them
ZA935697B (en) Peptides capable of inhibiting the activity of hiv protease their preparation and their therapeutic use
PL312718A1 (en) Competitors and opponents of human interleukine-10
EP0340333A3 (en) Novel physiologically active polypeptide and pharmaceutical composition
IL101350A0 (en) Preparation of alkanones and/or alkanols
HU9201254D0 (en) Rapamicine-carbamates and medical preparations containing them as active agents
IL108175A0 (en) Cloning and expression of xylanase B
PL296034A2 (en) Composition exibiting-fgf activity and method of obtaining same
IL101587A0 (en) Biologically active peptide composition and uses therefor
ZA882624B (en) Treatment of allergy and composition thereof
LTIP1736A (en) Derivatives of human bile-salt stimulated lipase, and pharmaceutical compositions containing them
IL99077A0 (en) New embodiments of the hiv principal neutralizing determinant and pharmaceutical compositions containing them
IL102565A0 (en) Expression of enzymatically active recombinant human acetylcholinesterase and uses thereof
ZA925514B (en) Expression of enzymatically active recombinant human actylcholinesterase and use thereof
IL98074A0 (en) Recombinant production of hirudins and novel hirudins
HU9202394D0 (en) Derivatives of cyclohexane and tetrahydro-pyrane
GB2294637B (en) Therapeutic compositions and methods of use
EP0577699A4 (en) Compositions and methods to inhibit the activation of active factor xiii.
EP0726964A4 (en) Isolation and composition of novel glycosidases
PL304896A1 (en) Cloning and expression of exo-polygalaktrurinase of aspergillus origin
EP0536960A3 (en) Preparation of 2-hydroxymandelic acids and 2-hydroxybenzaldehydes
PL307135A1 (en) Quinolinic and naphtyridinic precursors of drugs
AU8083591A (en) Therapy and prophylaxis of autoimmune diseases
AU3651689A (en) Cloning and expression of human tissue factor
CS4488A1 (en) Diagram of characteristics' group linearization and scaling